Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21091838 | 0.88 | TSHR (0.42) | ALDH1A1TSHR | |
| SCHEMBL21048939 | 0.87 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL27674660 | 0.86 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL29673032 | 0.77 | ALDH1A1 (0.46) | ALDH1A1TSHR | |
| SCHEMBL29120106 | 0.73 | ATM (0.39) | ALDH1A1 | |
| SCHEMBL2490971 | 0.73 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL21138744 | 0.72 | — | — | |
| SCHEMBL4058604 | 0.69 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL6052846 | 0.69 | — | — | |
| SCHEMBL23508853 | 0.66 | TSHR (0.40) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210015932-A1 | BIOORTHOGONAL COMPOSITIONS | TAMBO, INC. | 2021-01-21 | — | — | US | disclosed |
| US-10828373-B2 | Bioorthogonal compositions | TAMBO, INC. (US) | 2020-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10828373-B2 | Bioorthogonal compositions | CD47, EPHA2, MSN | ALDH1A1 2304/4885TSHR 3076/4885 |
| US-20210015932-A1 | BIOORTHOGONAL COMPOSITIONS | CD47, EPHA2, MSN | ALDH1A1 2304/4885TSHR 3076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.